百時美施貴寶公司
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionTOUCHSTONE VARIABLE SERIES TRUST - Touchstone Balanced Fund
Latest Disclosed Ownership7,348 shares
Latest Disclosed Value $ 340,138
TOUCHSTONE VARIABLE SERIES TRUST - Touchstone Balanced Fund reports 1.80% decrease in ownership of BMY / Bristol-Myers Squibb Company

On August 27, 2025 - TOUCHSTONE VARIABLE SERIES TRUST - Touchstone Balanced Fund filed a NPORT-P form disclosing ownership of 7,348 shares of Bristol-Myers Squibb Company (US:BMY) valued at $340,139 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 7,483 shares of Bristol-Myers Squibb Company. This represents a change in shares of -1.80% during the quarter. The current value of the position is $420,820 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 7,348 -135 -1.80 340 -25.44 0.7139
2025-05-29 2025-03-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 7,483 0 0.00 456 7.80 0.9772
2025-02-28 2024-12-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 7,483 -546 -6.80 423 1.93 0.8569
2024-11-22 2024-09-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 8,029 -583 -6.77 415 16.25 0.8169
2024-08-26 2024-06-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 8,612 0 0.00 358 -23.55 0.7054
2024-05-24 2024-03-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 8,612 -323 -3.61 467 1.97 0.8953
2024-02-28 2023-12-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 8,935 2,225 33.16 458 17.74 0.8996
2023-11-24 2023-09-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 6,710 0 0.00 389 -9.32 0.8154
2023-08-29 2023-06-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 6,710 -2,343 -25.88 429 -31.58 0.8367
2023-05-26 2023-03-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 9,053 -846 -8.55 627 -11.94 1.0997
2023-02-27 2022-12-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 9,899 -2,482 -20.05 712 -19.09 1.2945
2022-11-28 2022-09-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 12,381 0 0.00 880 -7.66 1.6552
2022-08-25 2022-06-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 12,381 -4,185 -25.26 953 -21.17 1.6668
2022-05-26 2022-03-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 16,566 -1,314 -7.35 1,210 8.53 1.7735
2022-02-25 2021-12-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 17,880 4,052 29.30 1,115 36.19 1.5418
2021-11-24 2021-09-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 13,828 646 4.90 818 -7.05 1.1333
2021-08-27 2021-06-30 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 13,182 9,409 249.38 881 269.75 1.2087
2021-05-27 2021-03-31 NP Bristol-Myers Squibb Company COM USD0.10 EC US1101221083 3,773 0 0.00 238 1.71 1.2543
2021-02-25 2020-12-31 NP Bristol-Myers Squibb Company COM EC US1101221083 3,773 0 0.00 234 3.08 1.2579
2020-11-25 2020-09-30 NP Bristol-Myers Squibb Company COM EC US1101221083 3,773 0 0.00 227 2.71 1.3124
2020-08-26 2020-06-30 NP Bristol-Myers Squibb Company COM EC US1101221083 3,773 0 0.00 222 5.24 1.3272
2020-05-29 2020-03-31 NP Bristol-Myers Squibb Company COM EC US1101221083 3,773 0 0.00 210 -13.22 1.4174
2020-02-28 2019-12-31 NP Bristol-Myers Squibb Company COM EC 110122108 3,773 -452 -10.70 242 13.08 1.3740
2019-11-26 2019-09-30 NP Bristol-Myers Squibb Company COM EC US1101221083 4,225 4,225 214 1.2873
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.